Articles From: - Telik and MabVax Therapeutics Announce Definitive Merger Agreement to - STMicroelectronics to Webcast Investors & Analysts Day


PALO ALTO, Calif.
Sign-up for - Telik and MabVax Therapeutics Announce Definitive Merger Agreement investment picks
SANTA ANA, Calif., May 12, 2014 (GLOBE NEWSWIRE) -- Corinthian Colleges, Inc. (Nasdaq:COCO) reported today that it had reached agreement with the lenders in its syndicated credit facility to amend the facility and to waive an event of default.
Sign-up for - Corinthian Colleges Receives Credit Facility Waiver investment picks
WUHAN CITY, China , May 12, 2014 /PRNewswire/ -- Tianli Agritech, Inc. (NASDAQ:OINK) ("Tianli" or the "Company"), a leading producer of breeder hogs, market hogs and black hogs headquartered in Wuhan City, China , today announced its financial results for the first quarter 2014 ended March 31, 2014 .
Sign-up for - Tianli Agritech, Inc. Reports First Quarter 2014 Results investment picks
Growth Driven by Strength in North American Education and Corporate Markets VANCOUVER , May 12, 2014 /PRNewswire/ - Absolute® Software Corporation ("Absolute" or the "Company") (TSX: ABT) , the industry standard for persistent endpoint security and management solutions for computers, laptops and ultra-portable devices and the data they contain, today announced its financial results for the three- and nine-month periods ended March 31, 2014 .
Sign-up for - Absolute Software Reports Fiscal 2014 Third Quarter Results investment picks
CANBERRA, Australia , May 12, 2014 /PRNewswire/ -- Northrop Grumman Corporation (NYSE: NOC) is collaborating with the Royal Melbourne Institute of Technology (RMIT) University, to study airworthiness requirements for operating unmanned aircraft systems (UAS) in Australia .
Sign-up for - Northrop Grumman, RMIT University Studying Operation of Unmanned Aircraft in Australia investment picks
http://media.marketwire.com/attachments/201405/74917_advent.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1114412&ProfileId=051205&sourceType=1 SAN FRANCISCO, CA --
Sign-up for - Advent Software Appoints Michael Frandsen to Board of Directors investment picks
ALPHARETTA, Ga., May 12, 2014 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) has received a patent issued by the U.S. Patent and Trademark Office entitled "Methods and Devices for Cleaning and Sterilization with Shock Waves." The claims of the patent (patent number 8,685,317) relate to the use of shock waves to clean and sterilize fluids in containers and/or pipes.
Sign-up for - SANUWAVE Receives U.S. Patent for Cleaning and Sterilization of Fluids and Food Liquids With Shock Waves investment picks
SAN FRANCISCO , May 12, 2014 /PRNewswire/ -- Digital Realty Trust, Inc. (NYSE: DLR) , a leading global provider of data center and colocation solutions, announced today that Interim Chief Executive Officer A.
Sign-up for - Digital Realty To Present At The J.P. Morgan Global Technology, Media And Telecom Conference investment picks
2014/5/12
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- Miners were among the best performers in the U.K. stock market Monday, helping to lift the benchmark FTSE 100 index, but British Sky Broadcasting Group PLC shares fell as the media firm sought control of pay-TV assets in Germany and Italy.
Sign-up for 2014/5/12 - UPDATE: Rio Tinto rises in U.K. trade, but BSkyB falls investment picks
Achieved Primary Endpoint of Complete Response (CR) in the Delayed Period (24 to 120 Hours) Following Initiation of Chemotherapy Achieved Key Secondary Endpoints of CR in the Acute and Overall Periods Achieved All Secondary Endpoints, Including No Significant Nausea Adverse Event Profile Consistent with Earlier Clinical Trials New Drug Application (NDA) Submission to U.S. FDA On Track for Mid-2014 WALTHAM, Mass., May 12, 2014 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) , an oncology-focused biopharmaceutical company, today announced positive top-line results from the third and final Phase 3 trial of rolapitant, an investigational neurokinin-1 (NK-1) receptor antagonist in development for the prevention of chemotherapy-induced nausea and vomiting (CINV). The rolapitant arm in this trial, which enrolled patients receiving cisplatin-based, highly emetogenic chemotherapy (HEC), successfully achieved statistical significance over the standard
Sign-up for - TESARO Announces Successful Achievement of Primary and All Secondary Endpoints in Third and Final Phase 3 Trial of Rolapitant investment picks
2014/5/12
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- European stocks were higher Monday, with mining shares advancing after an upgrade of the sector.
Sign-up for 2014/5/12 - European stocks gain as Rio Tinto, miners are upgraded investment picks
SINGAPORE , May 12, 2014 /PRNewswire/ -- China Yuchai International Limited (NYSE: CYD) ("China Yuchai" or the "Company") announced today that a dividend of US$1.20 per share of common stock for the financial year 2013 has been declared by its Board of Directors.
Sign-up for - China Yuchai International to Pay Dividend for FY 2013 in Cash Or Shares investment picks
2014/5/12
CHICAGO , May 12, 2014 /PRNewswire/ -- The Female Health Company (Nasdaq-CM: FHCO) today announced that it will be presenting at the 15 th Annual B.
Sign-up for 2014/5/12 - The Female Health Company To Present At 15th Annual B. Riley & Co. Investor Conference On May 19, 2014 investment picks
2014/5/12
Record Quarterly Revenue of $36.6 Million, Up 16.3% Year-Over-Year HOLON, Israel , May 12, 2014 /PRNewswire/ -- Sapiens International Corporation , (NASDAQ and TASE: SPNS), a leading global provider of software solutions for the insurance industry, with an emerging focus on the broader financial services sector, and a member of the Formula Group (NASDAQ: FORTY and TASE: FORT), announced today its financial results for the first quarter ended March 31, 2014 .
Sign-up for 2014/5/12 - Sapiens Reports Results for the First Quarter 2014 investment picks
2014/5/12
Provides Guidance of Revenue and Net Income for the Fourth Quarter of Fiscal Year 2014, and Updates Guidance of Revenue and Net Income for Fiscal Year 2014 XI'AN, China, May 12, 2014 /PRNewswire-FirstCall/ -- Third Quarter of FY 2014 net sales increased 6.7% to $70.3 million; net income decreased 46.2% to $7.2million with EPS of $0.23. The Company Provided Fourth Quarter of Fiscal Year 2014 Guidance Range: Revenue, Net Income and EPS of between $60 million and $70 million , $6 million and $7 million , and $0.19 and $ 0.22 based on 31.8 million numbers of fully diluted shares, respectively.
Sign-up for 2014/5/12 - China Green Agriculture, Inc. Reports the Financial Results for the Third Quarter of Fiscal Year 2014 investment picks
DUBLIN , May 12, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that it has entered into an agreement with Valeant Pharmaceuticals International to settle all outstanding patent litigation related to Actavis' generic version of Acanya ® (clindamycin phosphate and benzoyl peroxide) Gel, 1.2%/2.5%. Acanya ® Gel is a lincosamide antibiotic and benzoyl peroxide indicated for the topical treatment of acne vulgaris.
Sign-up for - Actavis Announces Acanya® Gel Patent Challenge Settlement investment picks
LONDON (MarketWatch) -- Hillshire Brands Co.
Sign-up for - UPDATE: Hillshire Brands to buy Pinnacle Foods for $6.6 billion investment picks
ROCK HILL, S.C., May 12, 2014 (GLOBE NEWSWIRE) -- 3D Systems (NYSE:DDD) announced today that it has partnered with ScanSource, Inc. (Nasdaq:SCSC) , the leading international value-added distributor of specialty technology products, on ScanSource's new technologies team dedicated to the sale and support of 3D printing solutions.
Sign-up for - 3D Systems Expands Distribution Footprint Through Partnership With ScanSource investment picks
PARSIPPANY, N.J. , May 12, 2014 /PRNewswire/ -- Pinnacle Foods Inc. (NYSE: PF) announced today that it has entered into a definitive agreement for the sale of the Company to Hillshire Brands (NYSE: HSH) in a transaction to include cash and Hillshire common stock.
Sign-up for - Pinnacle Foods Inc. Signs Definitive Agreement for Sale of Company to Hillshire Brands investment picks
JACKSONVILLE, Fla., May 12, 2014 (GLOBE NEWSWIRE) -- Web.com (Nasdaq:WWWW) , a leading provider of Internet services and online marketing solutions for small businesses, invites small business owners in the greater Greenville, South Carolina area to join them as VIP guests at the upcoming Web.com Tour BMW Charity Pro-Am presented by SYNNEX Corporation.
Sign-up for - Web.com to Host Small Business Owners at the Upcoming BMW Charity Pro-Am in Greenville investment picks
EWING, N.J., May 12, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. , (Nasdaq:CPXX) , a pharmaceutical company developing new and more effective therapies to treat cancer, today announced that it has entered into a loan agreement with Hercules Technology Growth Capital, Inc. (NYSE:HTGC) , a specialty finance company that provides customized debt financing to companies in life sciences and technology-related markets.
Sign-up for - Celator(R) Pharmaceuticals Secures Loan Agreement With Hercules Technology Growth Capital investment picks
LAFAYETTE, Ind.
Sign-up for - LSB Financial Corp. Announces First Quarter Results investment picks
STEVENSON, Md., May 12, 2014 (GLOBE NEWSWIRE) -- Brower Piven, A Professional Corporation announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of Weight Watchers International, Inc. ("Weight Watchers" or the "Company") (NYSE:WTW) common stock during the period between February 14, 2012 and October 30, 2013, inclusive (the "Class Period"). If you have suffered a loss from investment in Weight Watchers common stock purchased on or after February 14, 2012 and held through the revelation of negative information on October 30, 2013, as described below, and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, without cost or financial obligation, click here: http://www.browerpiven.com/securitiesfraudcases.html .
Sign-up for - SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Weight Watchers International, Inc. to Contact Brower Piven Before the May 20, 2014 Lead Plaintiff Deadline -- WTW investment picks
LOS ANGELES , May 12, 2014 /PRNewswire/ -- CannaMed Corp.
Sign-up for - CannaMed Corporation Names Industry Veteran Paul Shively as Chief Financial Officer investment picks
CLEARWATER, Fla., May 12, 2014 (GLOBE NEWSWIRE) -- Nicholas Financial, Inc. (Nasdaq:NICK) announced that the Company's Board of Directors (the "Board") held a special meeting to consider the status of the Company's proposed transaction with Prospect Capital Corporation ("Prospect"). As previously disclosed in a Current Report on Form 8-K filed December 18, 2013, on December 17, 2013, the Company entered into an arrangement agreement (the "Arrangement Agreement") whereby the Company agreed to sell all of its issued and outstanding Common Shares to an indirect wholly-owned subsidiary of Prospect, pursuant to a plan of arrangement (the "Arrangement") under the Business Corporations Act (British Columbia). Prospect (Nasdaq:PSEC) ( www.prospectstreet.com ) is a closed-end investment company that has filed an election to be treated as a business development company under the Investment Company Act of 1940.
Sign-up for - Nicholas Financial Makes Announcement Regarding Status of Arrangement Agreement With Prospect Capital investment picks
GENEVA, May 12, 2014 (GLOBE NEWSWIRE) -- STMicroelectronics (NYSE:STM) , a global semiconductor leader serving customers across the spectrum of electronics applications, announced that it will webcast live its 2014 Investors & Analysts meeting from New York, USA, on Thursday, May 15, from 9:00 am to 1:00 pm EDT (3:00 pm - 7:00 pm CET). The live webcast featuring video, audio and presentation slides can be accessed through the Investor Relations section http://investors.st.com of ST's web site.
Sign-up for - STMicroelectronics to Webcast Investors & Analysts Day investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: - Telik and MabVax Therapeutics Announce Definitive Merger Agreement to - STMicroelectronics to Webcast Investors & Analysts Day
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry